SAN JOSE, Calif., Feb. 24 /PRNewswire-FirstCall/ -- Sanmina-SCI Corporation , a leading global Electronics Manufacturing Services (EMS) company, today announced that its Tatabanya, Hungary facility has received ISO 13485 certification for medical device manufacturing.
"We are very pleased to have received the ISO 13485 certification which demonstrates Sanmina-SCI's commitment to maintain the highest medical device manufacturing standards in the EMS industry," said Gelston Howell, Senior Vice President of Sanmina-SCI's Medical Division. "Earning this certification represents a significant milestone for our European operations, plus reinforces our leadership position within the medical device market segment and our strategy to support customers on a global basis."
Sanmina-SCI's Medical Division leverages more than 20 years of experience with a large global network of FDA-registered, ISO 13485:2003 compliant medical design and manufacturing facilities in the EMS industry. The Medical Division offers medical device Original Equipment Manufacturers (OEMs) complete end-to-end manufacturing services from engineering and manufacturing to logistics and repair/returns management, specializing in a full range of medical devices, from small and medium-sized products, such as blood pressure monitors and prostate therapy systems to large equipment that includes CT scanners and ultrasound systems.
Sanmina-SCI Safe Harbor Statement
The foregoing, including the discussion regarding the Company's future prospects, contains certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with economic conditions in the electronics industry, particularly in the principal industry sectors served by the Company, changes in customer requirements and in the volume of sales to principal customers, the ability of Sanmina-SCI to effectively assimilate acquired businesses and achieve the anticipated benefits of its acquisitions, and competition and technological change. The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors, including factors set forth in the Company's fiscal year 2009 Annual Report on Form 10-K and the other reports, including quarterly reports on Form 10-Q and current reports on Form 8-K, that the Company files with the Securities Exchange Commission.
CONTACT: Michael Kovacs, Director, Marketing & Public Relations,
+1-408-964-3142, michael.kovacs@sanmina-sci.com, or Paige Bombino, Investor
Relations, +1-408-964-3610, for Sanmina-SCI Corporation
Web site: http://www.sanmina-sci.com/
